From The New York Times -- Odds and Ends in Health Care. . . .

From The New York Times, this morning:

Statin May Protect Patients With Low Cholesterol, Researchers Say

. . . .Research presented on Thursday at the American Stroke Association meeting in San Diego suggest that daily treatment with the statin Crestor benefits even people with low levels of cholesterol. Bloomberg News reports that AstraZeneca, the drug's manufacturer, plans to file a request with the Food and Drug Administration for expanded approval of the medicine. . . .

This development will likely place an additional roadblock before Schering-Plough's highly priced drug, Vytorin -- in its quest to return to any market share stabilization or growth, in the United States.